Target intelligence / Profile preview

Calmodulin (CaM) (CaM)

Target
CaM
Molecular classification
Calcium-binding protein, Signaling molecule
01

Overview

Calmodulin (CaM) is a ubiquitous, highly conserved calcium-binding messenger protein that serves as a primary sensor of intracellular calcium levels in eukaryotic cells [3, 12]. Upon binding calcium ions, CaM undergoes a conformational change that allows it to interact with and regulate a wide array of target proteins, including kinases such as CaMKII and CaMKK, phosphatases like calcineurin, and various ion channels [3, 6, 14]. This signaling network, often referred to as Calmodulin-dependent signaling, is critical for diverse physiological processes including muscle contraction, synaptic plasticity, cell cycle progression, and inflammation [3, 18, 20]. Dysregulation of this pathway is implicated in various pathologies, notably cardiac arrhythmias and heart failure due to aberrant CaMKII activity, as well as several types of cancer where CaM-dependent kinases promote cell proliferation and survival [1, 5, 9, 13]. Pharmacological modulation has been explored using CaM antagonists like trifluoperazine and specific kinase inhibitors like KN-93, though the ubiquity of CaM presents significant challenges for achieving therapeutic selectivity and minimizing off-target effects [1, 12, 17]. In the heart, CaM-dependent signaling regulates excitation-contraction coupling, and its overactivation is a hallmark of maladaptive remodeling [5, 15, 19]. In the brain, it is essential for long-term potentiation and memory formation, making it a sensitive target for neurological side effects [3, 8, 14].

Other names
Calcium-modulated proteinCALM1CALM2CALM3Calmodulin-1Calmodulin-2Calmodulin-3Calmodulin-dependent signaling
02

Mechanism of action

Calmodulin inhibition, CaMKII inhibition, and calcium-dependent binding to target proteins.

03

Biological functions

Signal transductionCalcium signalingMuscle contractionCell cycleApoptosisSynaptic plasticity
04

Disease associations

Cardiovascular diseaseCancerNeurodegenerative diseaseInflammation
05

Safety considerations

Off-target effects due to ubiquityPotential for cardiac arrhythmiasCognitive impairmentSystemic toxicity
06

Interacting drugs

Trifluoperazine

5 more in the full profile.

07

Biomarkers

Phospho-CaMKII (T286)CALM1/2/3 mutationsIntracellular calcium levels

Beyond the preview

Go deeper on Calmodulin (CaM) (CaM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calmodulin (CaM) (CaM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call